Gencurix Inc. provides diagnostic solutions in South Korea. Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detection. The company has a strategic alliance with Qiagen N.V. for the development of oncology assays for use on the QIAcuityDx platform. The company was founded in 2011 and is headquartered in Seoul, South Korea.
Metrics to compare | 229000 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship229000PeersSector | |
---|---|---|---|---|
P/E Ratio | −2.0x | −3.3x | −0.5x | |
PEG Ratio | −0.04 | 0.00 | 0.00 | |
Price/Book | 2.4x | 1.5x | 2.6x | |
Price / LTM Sales | 7.5x | 3.3x | 3.3x | |
Upside (Analyst Target) | - | 230.3% | 43.5% | |
Fair Value Upside | Unlock | 11.9% | 6.3% | Unlock |